The Menin Inhibitor SNDX-5613 (revumenib) Leads to Durable Responses in Patients (Pts) with KMT2A-Rearranged or NPM1Mutant AML: Updated Results of a Phase (Ph) 1 Study
| Autor: | Issa, Ghayas C., Aldoss, Ibrahim, DiPersio, John F., Cuglievan, Branko, Stone, Richard M., Arellano, Martha L., Thirman, Michael J., Patel, Manish R., Dickens, David, Shenoy, Shalini, Shukla, Neerav, Rosen, Galit, Bagley, Rebecca G., Meyers, Michael L., Madigan, Kate, Ordentlich, Peter, Gu, Yu, Smith, Steven, McGeehan, Gerard M., Stein, Eytan |
|---|---|
| Zdroj: | Blood; November 2022, Vol. 140 Issue: 1, Number 1 Supplement 1 p150-152, 3p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|